ACTIVITÉ CONTRE L’ACCUMULATION DE TARTRE – ÉTUDE CLINIQUE OFFERTE EN ANGLAIS UNIQUEMENT

Dental calculus forms through the mineralization of dental plaque, resulting in a variety of different crystalline forms (Sidaway 1978). First, new crystals form, that are composed of calcium and phosphate, which then grow and harden into calculus (Figures 18-19). The mineral content for supragingival and subgingival calculus is on average 37% and 58% by volume, respectively (Friskopp & Isacsson 1984). Supragingival calculus also contains bacterial debris and toxins as well as viable aerobic and anaerobic bacteria (Tan et al. 2004a; Tan et al. 2004b; White et al. 1997). This is of clinical significance as it can be a reservoir of pathogenic bacterial species (Tan et al. 2004b). Dental calculus is common in adults, and less common in children (Anerud et al. 1991).

Figure 18. Formation of dental calculus

Figure 18. Formation of dental calculus

In the 2-step and smooth texture formulas, the positively charged zinc ion (Zn2+) inhibits crystal growth by substituting for calcium in the crystal lattice of calcium phosphate (Figure 22). This interferes with the crystal formation and slows crystal growth (Segreto et al. 1991). Stannous fluoride also inhibits plaque formation, which is the structure on which calcium and phosphate precipitate.

Figure 19. Supragingival calculus

Figure 19. Supragingival calculus

Figure 20. Hexametaphosphate molecule

Figure 20. Hexametaphosphate molecule

Mechanism of action

Pyrophosphate helps to reduce dental calculus through a mineral chelating effect that inhibits plaque mineralization. It has a natural binding affinity for calcium ions. The anticalculus effect is due to adsorption and binding of the pyrophosphate to the tooth surface and to forming crystals of calcium phosphate in plaque, helping to inhibit the growth and maturation of calculus (White & Gerlach 2000; Rykke & Rolla 1990; Rolla et al. 1988). Sodium hexametaphosphate (Figure 20) is a longer-chain form of pyrophosphate, with more binding sites. It has a greater affinity for hydroxyapatite surfaces, and binds strongly to the tooth surface and the surface of developing calculus in plaque. (Figure 21 White & Gerlach 2000; Baig et al. 2002, Busscher et al. 2002)

Figure 21. Mechanism of action of sodium hexametaphosphate

Figure 21. Mechanism of action of sodium hexametaphosphate

In the 2-step and smooth texture formulas, the positively charged zinc ion (Zn2+) inhibits crystal growth by substituting for calcium in the crystal lattice of calcium phosphate (Figure 22). This interferes with the crystal formation and slows crystal growth (Segreto et al. 1991). Stannous fluoride also inhibits plaque formation, which is the structure on which calcium and phosphate precipitate.

Figure 22. Mechanism of action of zinc

Figure 22. Mechanism of action of zinc

CALCULUS RESEARCH SUMMARIES

The following study summaries represent a sample of research demonstrating the benefits of stabilized stannous fluoride dentifrice for calculus inhibition.

ANTICALCULUS EFFICACY AND SAFETY OF A STABILIZED STANNOUS FLUORIDE DENTIFRICE WITH HEXAMETAPHOSPHATE

Full text available in the Research Database at www.dentalcare.comReference: Schiff T, Saletta L, Baker RA, et al. Compend Contin Educ Dent. 2005; 26(9 suppl 1):29-34.

OBJECTIVE

To assess the anticalculus efficacy of a 0.454% stabilized stannous fluoride dentifrice with sodium hexametaphosphate vs a positive control dentifrice.

MATERIALS AND METHODS

• A 0.454% stabilized stannous fluoride dentifrice with sodium hexametaphosphate was compared to a marketed tartar control (0.30% triclosan/0.243% sodium fluoride/2% Gantrez copolymer) dentifrice.

• The Volpe-Manhold Index was used to measure calculus on the lingual surfaces of the lower 6 anterior teeth.

• Oral soft and hard tissue examinations were also conducted.

• The Lobene Index was used to measure stain on the facial surfaces of 12 anterior teeth.

• Subjects were randomized to either the stabilized stannous fluoride/sodium hexametaphosphate dentifrice or the control dentifrice..

• Subjects used their assigned dentifrice twice a day for 6 months.

• Subjects were examined again for calculus, stain, and soft tissue safety at months 3 and 6.

RESULTS

• Data were analyzed for 80 subjects who had complete data.

• Volpe-Manhold Index scores were statistically significantly lower for the stabilized stannous fluoride/sodium hexametaphosphate group than the triclosan/sodium fluoride copolymer group at both months 3 and 6 (P<0.0001).

• Compared to the triclosan/sodium fluoride copolymer group, the stabilized stannous fluoride/sodium hexametaphosphate group showed a 54% reduction (adjusted means) in calculus accumulation at month 3 and a 56% reduction at month 6.

• Neither group of subjects showed any appreciable extrinsic stain accumulation.

• No adverse events were reported.

A RANDOMIZED CLINICAL TRIAL TO EVALUATE A DAILY TWO-STEP DENTIFRICE AND GEL SYSTEM IN THE PREVENTION OF STAIN, PLAQUE AND CALCULUS FOLLOWING A DENTAL PROPHYLAXIS

Reference: Gerlach R, Farrell S, Anastasia MK, Amini P. J Dent Res 2016; 95 (Spec Iss A): Abstract 0093.

KEY CLINICAL FINDINGS

• A 2-step dentifrice and whitening gel system helped maintain the cleaning results of a dental prophylaxis versus a regular anti-cavity dentifrice used as a negative control through 2.5 months. Step 1 is a 0.454% stannous fluoride dentifrice and Step 2 is a 3% hydrogen peroxide whitening gel.

• After 10 weeks of twice daily use, the 2-step dentifrice and gel system exhibited statistically lower (P<0.001) percent accumulations versus the control group in tooth stain (73.4%), plaque (30.5%), and calculus (58.6%). See Figures 1–3.

• Both products were well-tolerated.

Figure 1. Tooth Stain Scores

Figure 1. Tooth Stain Scores

• Baseline and post-prophy scores are means; Week 4 and Week 10 scores are adjusted means ** P<0.0005

Figure 2. Plaque Scores

Figure 2. Plaque Scores

** Baseline and post-prophy scores are means; Week 4 and Week 10 scores are adjusted means. ** P<0.0001

Figure 3. Calculus Scores

Figure 3. Calculus Scores

• Baseline and post-prophy scores are means; Week 4 and Week 10 scores are adjusted means. ** P<0.01

OBJECTIVE

To assess the effectiveness of a daily 2-step dentifrice and gel system to prevent the formation of stain, calculus and plaque after a dental prophylaxis.

METHODS

• This was a randomized, controlled, examiner-blind, 2-treatment parallel group study. Forty-eight healthy adult volunteers with evidence of plaque and either stain or calculus completed the trial.

• Following a whole-mouth dental prophylaxis, subjects were randomized to one of two groups:

- Negative control - 0.76% sodium monofluorophosphate dentifrice (Colgate® Cavity Protection, Colgate-Palmolive)

- Daily 2-step dentifrice and gel system (Crest® PRO-HEALTH™ [HD]™) - Step 1, 0.454% stannous fluoride dentifrice; Step 2, 3% hydrogen peroxide whitening gel

Both groups brushed twice daily with a soft manual toothbrush (Oral-B® Indicator™, Procter & Gamble).

• Stain (Lobene Index1), calculus (Volpe-Manhold Index2) and plaque (Rustogi Modification of the Navy Plaque Index3) were measured clinically prior to receiving a dental prophylaxis, immediately after a dental prophylaxis, and after 4 and 10 weeks of product use.

1 Lobene RR. Effect of dentifrices on tooth stain with controlled brushing. J Am Dent Assoc. 1968;77:849-855. 2 Volpe AR, Manhold JH, Hazen SP. In vivo calculus assessment. I. A method and its examiner reproducibility. J Periodontol. 1965;36:32-38. 3 Rustogi KN, Curtis JP, Volpe AR, Kemp JH, McCool JJ, Korn LR. Refinement of the modified Navy Plaque Index to increase efficiency in gumline and interproximal tooth areas. J Clin Dent. 1992;3 (Suppl C):C9-12.

ANTI-CALCULUS EFFICACY OF A STABILIZED STANNOUS FLUORIDE DENTIFRICE IN A 3-MONTH CLINICAL TRIAL

Reference: Milleman JL, He T, Anastasia MK. J Dent Res 2017; 96 (Spec Iss A): Abstract 2816.

KEY CLINICAL FINDINGS

• Subjects using the stabilized stannous fluoride (SnF2₂) dentifrice demonstrated 15.1% less calculus at Week 6 (P=0.05) and 21.7% less calculus at Month 3 (P<0.01) compared to subjects in the control group.

• Both test products were well tolerated.

N=78. *Significant difference between groups (P<0.05) using analysis of covariance.

OBJECTIVE

To assess the calculus prevention benefit of an experimental stabilized SnF2 dentifrice relative to a negative control dentifrice.

STUDY DESIGN

• This was a 3-month, parallel-group, double-blind, randomized and controlled clinical trial.

• Subjects received a dental prophylaxis and then entered a 2-month run-in phase. At the end of 2 months, subjects received a Volpe-Manhold Index (V-MI) calculus examination.

• Qualified subjects who formed a minimum of 9 mm of calculus on the lingual surfaces of the six mandibular anterior teeth received another prophylaxis and were randomly assigned to one of the two treatments:

•  

• - Experimental 0.454% stabilized SnF2 dentifrice (Crest® PRO-HEALTH™ Clean Mint [Smooth Formula], Procter & Gamble) with zinc to control calculus; or

• - Negative control dentifrice (Colgate® Cavity Protection, Colgate-Palmolive).

•  

• Subjects brushed with their assigned product twice daily using a standard manual toothbrush, one minute per brushing, during the 3-month trial.

• Safety and calculus measurements were taken via Oral Soft Tissue and Volpe-Manhold Index examinations at Baseline, Week 6 and Month 3..

• Treatment groups were compared using analysis of covariance. All statistical tests were two-sided with a 5% level of significance.

CLINICAL SIGNIFICANCE: CALCULUS

• Calculus has a rough surface which has greater potential for more plaque build-up than smooth, clean surfaces.
• The ability to prevent and control calculus formation with twice-daily use of anti-calculus stabilized stannous fluoride toothpastes helps patients be able to brush more efficiently without accumulations of dental calculus interfering with brushing.
• Less dental calculus also means that patients will have easier, more efficient dental cleanings.